Rituximab in patients with membranous nephropathy and kidney insufficiency

Introduction: Patients with membranous nephropathy and kidney insufficiency have an extremely high risk of progression to end-stage renal disease. Whether rituximab can effectively treat membranous nephropathy patients with renal dysfunction remains unknown at present. The aim of our study was to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yanhong, Wang, Liuwei, Wang, Yulin, Li, Xiaodan, Zhai, Zihan, Yu, Lu, Liang, Yan, Liu, Peipei, Tang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589416/
https://www.ncbi.nlm.nih.gov/pubmed/36299887
http://dx.doi.org/10.3389/fphar.2022.1002117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589416/
https://www.ncbi.nlm.nih.gov/pubmed/36299887
http://dx.doi.org/10.3389/fphar.2022.1002117

Ejemplares similares